Home > Analytics > SUDARSHAN PHARMA INDUSTRIES

SUDARSHAN PHARMA INDUSTRIES
Intrinsic Value | Fundamental Analysis

BOM : 543828     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Jul 22,2026
Price(EOD): ₹ 40.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 1,003.79 Cr
Value of ₹ 1 Lac invested in SUDARSHAN PHARMA INDUSTRIES
on Mar 22,2023 (price: ₹ 6.94)

₹ 1 L

₹ 5.80 L

1W : -0.3% 1M : 7.3% 1Y : 47.1%
COMMUNITY POLL
for SUDARSHAN PHARMA INDUSTRIES
Please provide your vote to see the results
SUDARSHAN PHARMA INDUSTRIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
SUDARSHAN PHARMA INDUSTRIES -0.3% 7.3% 47.1%
SUN PHARMACEUTICAL INDUSTRIES -0.4% 4.3% 13.6%
DIVIS LABORATORIES 0.9% 8.9% 8%
TORRENT PHARMACEUTICALS 0.7% 13% 46.5%
CIPLA -1% -0% -3.9%
DR REDDYS LABORATORIES -3.3% -8.4% -4.3%
MANKIND PHARMA -0% 0.3% -2.8%
LUPIN -3.8% 2.8% 28.9%
ZYDUS LIFESCIENCES -2.1% 4.2% 18.3%

FUNDAMENTAL ANALYSIS OF SUDARSHAN PHARMA INDUSTRIES

 
Fundamentals Score
[ Q(TTM): Mar2026, Y: Mar2025
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]



VALUATION OF SUDARSHAN PHARMA INDUSTRIES

 
Valuation Score
[As on : Jul 22,2026 ]

Ratio Consolidated
P/E
P/B
P/S
42.95
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 23.37 Cr
[Latest Qtr - Mar2026 - Consolidated Results ]

6.47
P/B Calculated based on Book Value of Rs 155.10 Cr
[Latest Year - Mar2026 - Consolidated Results ]

1.43
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 703.06 Cr
[Latest Qtr - Mar2026 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 26% undervalued companies ! Discover More →

FAIR VALUE OF SUDARSHAN PHARMA INDUSTRIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
895%
NA (-ve EV)
170%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF SUDARSHAN PHARMA INDUSTRIES


Insights 💡 SUDARSHAN PHARMA INDUSTRIES is one of the top 27% companies with bullish price momentum currently! Discover More →

SUDARSHAN PHARMA INDUSTRIES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF SUDARSHAN PHARMA INDUSTRIES

Year Debt/Equity ratio
Standalone Consolidated
2025
2024
2023
Avg_3yrs
1.36
0.96
0.34
0.89
1.34
0.94
0.34
0.87
[Last Annual Data : Mar2025]
Financial Ratios →

PLEDGED PROMOTER SHARES OF SUDARSHAN PHARMA INDUSTRIES

Pledged Promoter Shares
0 %
As on : Mar2026

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF SUDARSHAN PHARMA INDUSTRIES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
31.5%
85.8%
202.12%
174.64%
36.71%
26.78%
58.77%
53.68%
QtrlyTrend
8
Latest Qtr: Mar2026
Quarterly Result Analysis →

Insights 💡 SUDARSHAN PHARMA INDUSTRIES is one of the top 53% companies with good quarterly result uptrend ! Discover More →

SUDARSHAN PHARMA INDUSTRIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about SUDARSHAN PHARMA INDUSTRIES


Is SUDARSHAN PHARMA INDUSTRIES good for long term investment?

As on Jul 22,2026, the Fundamentals of SUDARSHAN PHARMA INDUSTRIES look Poor and hence it may not be good for long term investment ! See Financial Performance of SUDARSHAN PHARMA INDUSTRIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is SUDARSHAN PHARMA INDUSTRIES UnderValued or OverValued?

As on Jul 22,2026, SUDARSHAN PHARMA INDUSTRIES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of SUDARSHAN PHARMA INDUSTRIES ?

As on Jul 22,2026, the Intrinsic Value of SUDARSHAN PHARMA INDUSTRIES is Rs. 9.47 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 4.04
Fair Value [Median EV / Sales Model] : Rs. -1.65
Fair Value [Median Price / Sales Model] : Rs. 14.89
Estimated Median Fair Value of SUDARSHAN PHARMA INDUSTRIES : Rs. 9.47

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is SUDARSHAN PHARMA INDUSTRIES trading at a Premium or Discount?

As on Jul 22,2026, SUDARSHAN PHARMA INDUSTRIES is trading at a Premium of 325% based on the estimates of Median Intrinsic Value!